Showing 1,181 - 1,200 results of 1,791 for search '(( 10 ((peer decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 10 i decrease ))*', query time: 0.26s Refine Results
  1. 1181
  2. 1182
  3. 1183
  4. 1184

    Enhanced bioelectrochemical treatment of petroleum refinery wastewater with Labaneh whey as co-substrate by Mohanakrishna, Gunda

    Published 2020
    “…Among several concentrations of LW as co-substrate in the range of 5–30% (v/v) with PRW, 85:15 (PRW:LW) showed to have the highest power generation (power density (PD), 832 mW/m2), which is two times higher than the control with PRW as sole substrate (PD, 420 mW/m2). On the contrary, a maximum substrate degradation rate of 0.420 kg COD/m3-day (ξCOD, 63.10%), was registered with 80:20 feed. …”
    Get full text
    Get full text
  5. 1185
  6. 1186
  7. 1187
  8. 1188

    Salvia fruticosa Induces Vasorelaxation in Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway by Anwar, M. Akhtar

    Published 2017
    “…Prior exposure to PI3K inhibitors, wortmannin (0.1 µM) or LY294002 (10 µM), decreased cGMP accumulation and attenuated the SF-induced vasorelaxation by approximately 50% (Rmax). …”
    Get full text
    Get full text
  9. 1189

    Continuous adsorptive removal of glimepiride using multi-walled carbon nanotubes in fixed-bed column. by Badran, ismail

    Published 2021
    “…The maximum adsorption capacity (q) was 275.3 mg/g, and the axial dispersion coefficients were ranged between 3.5 and 9.0 × 10 m/s. The spent adsorbent was successfully regenerated at high pH by flushing with NaOH.…”
    Get full text
    Get full text
  10. 1190
  11. 1191

    Adaptive thermal comfort in the different buildings of Darjeeling Hills in eastern India – Effect of difference in elevation by Thapa, Samar

    Published 2018
    “…In this paper, the results of field studies conducted in 10 buildings of different types located in varying elevation are presented. …”
    Get full text
    Get full text
  12. 1192

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Each patient's medications for the past four months were tallied, and a definitional threshold of ≤4, ≥5, ≥10 medications was established. …”
    Get full text
    Get full text
    Get full text
  13. 1193
  14. 1194
  15. 1195
  16. 1196

    Awareness of disabilities in pharmacy program recruitment material: are we doing enough? by Hussain, Farhat Naz

    Published 2020
    “…Introduction: Targeted recruitment of students with disabilities is a novel area in pharmacy education and may help to attract qualified students in light of decreasing applicant numbers. …”
    Get full text
    Get full text
  17. 1197

    Enhanced bioelectrochemical treatment of petroleum refinery wastewater with Labaneh whey as co-substrate by Mohanakrishna, Gunda

    Published 2020
    “…Among several concentrations of LW as co-substrate in the range of 5–30% (v/v) with PRW, 85:15 (PRW:LW) showed to have the highest power generation (power density (PD), 832 mW/m2), which is two times higher than the control with PRW as sole substrate (PD, 420 mW/m2). On the contrary, a maximum substrate degradation rate of 0.420 kg COD/m3-day (ξCOD, 63.10%), was registered with 80:20 feed. …”
    Get full text
    Get full text
    Get full text
  18. 1198
  19. 1199
  20. 1200